Laboratory of Chemistry of Biologically Active Compounds, Faculty of Chemistry, University of Gdańsk, Wita Stwosza 63, 80-308 Gdańsk, Poland.
Department of Medical Microbiology, Faculty of Medicine, Medical University of Gdańsk, Dębowa 25, 80-204 Gdańsk, Poland.
Int J Mol Sci. 2022 Jul 27;23(15):8269. doi: 10.3390/ijms23158269.
Mastoparan (MP) is an antimicrobial cationic tetradecapeptide with the primary structure INLKALAALAKKIL-. This amphiphilic α-helical peptide was originally isolated from the venom of the wasp . MP shows a variety of biological activities, such as inhibition of the growth of Gram-positive and Gram-negative bacteria, as well as hemolytic activity and activation of mast cell degranulation. Although MP appears to be toxic, studies have shown that its analogs have a potential therapeutic application as antimicrobial, antiviral and antitumor agents. In the present study we have designed and synthesized several new chimeric mastoparan analogs composed of MP and other biologically active peptides such as galanin, RNA III inhibiting peptide (RIP) or carrying benzimidazole derivatives attached to the ε-amino side group of Lys residue. Next, we compared their antimicrobial activity against three reference bacterial strains and conformational changes induced by membrane-mimic environments using circular dichroism (CD) spectroscopy. A comparative analysis of the relationship between the activity of peptides and the structure, as well as the calculated physicochemical parameters was also carried out. As a result of our structure-activity study, we have found two analogs of MP, MP-RIP and RIP-MP, with interesting properties. These two analogs exhibited a relatively high antibacterial activity against compared to the other MP analogs, making them a potentially attractive target for further studies. Moreover, a comparative analysis of the relationship between peptide activity and structure, as well as the calculated physicochemical parameters, may provide information that may be useful in the design of new MP analogs.
蜂毒素(MP)是一种具有十四肽结构的抗菌阳离子肽,其一级结构为 INLKALAALAKKIL-。这种两亲性α-螺旋肽最初是从黄蜂毒液中分离出来的。MP 表现出多种生物学活性,如抑制革兰氏阳性和革兰氏阴性细菌的生长,以及溶血活性和肥大细胞脱颗粒的激活。尽管 MP 似乎有毒性,但研究表明,其类似物作为抗菌、抗病毒和抗肿瘤药物具有潜在的治疗应用。在本研究中,我们设计并合成了几种由 MP 和其他具有生物活性的肽(如甘丙肽、RNA III 抑制肽(RIP)或携带连接到赖氨酸残基的ε-氨基侧基的苯并咪唑衍生物)组成的新型嵌合蜂毒素类似物。接下来,我们比较了它们对三种参考细菌菌株的抗菌活性以及在膜模拟环境中诱导的构象变化,使用圆二色性(CD)光谱法。还对肽活性与结构之间的关系以及计算的物理化学参数进行了比较分析。作为我们的结构-活性研究的结果,我们发现了两种类似物,MP-RIP 和 RIP-MP,它们具有有趣的特性。这两种类似物对 表现出相对较高的抗菌活性,与其他 MP 类似物相比,这使得它们成为进一步研究的潜在有吸引力的目标。此外,肽活性与结构之间关系以及计算的物理化学参数的比较分析可能提供可能有助于设计新的 MP 类似物的信息。